Human cancer evolution in the context of a human immune system in mice

por Gammelgaard, Odd L., Terp, Mikkel G., Preiss, Birgitte, Ditzel, Henrik J.
Publicado 2018

Sustained compensatory p38 MAPK signaling following treatment with MAPK inhibitors induces the immunosuppressive protein CD73 in cancer: combined targeting could improve outcomes

por Terp, Mikkel G., Gammelgaard, Odd L., Vever, Henriette, Gjerstorff, Morten F., Ditzel, Henrik J.
Publicado 2021

PDX Models: A Versatile Tool for Studying the Role of Myeloid-Derived Suppressor Cells in Breast Cancer

por Gjerstorff, Morten F., Traynor, Sofie, Gammelgaard, Odd L., Johansen, Simone, Pedersen, Christina B., Ditzel, Henrik J., Terp, Mikkel G.
Publicado 2022

Targeting two distinct epitopes on human CD73 with a bispecific antibody improves anticancer activity

por Gammelgaard, Odd L, Terp, Mikkel G, Renn, Christian, Labrijn, Aran F, Hamaker, Oliver, Nielsen, Aaraby Y, Vever, Henriette, Hansen, Soren WK, Gjerstorff, Morten F, Müller, Christa E, Parren, Paul WHI, Ditzel, Henrik J
Publicado 2022

Co-targeting CDK4/6 and AKT with endocrine therapy prevents progression in CDK4/6 inhibitor and endocrine therapy-resistant breast cancer

por Alves, Carla L., Ehmsen, Sidse, Terp, Mikkel G., Portman, Neil, Tuttolomondo, Martina, Gammelgaard, Odd L., Hundebøl, Monique F., Kaminska, Kamila, Johansen, Lene E., Bak, Martin, Honeth, Gabriella, Bosch, Ana, Lim, Elgene, Ditzel, Henrik J.
Publicado 2021

Publisher Correction: Co-targeting CDK4/6 and AKT with endocrine therapy prevents progression in CDK4/6 inhibitor and endocrine therapy-resistant breast cancer

por Alves, Carla L., Ehmsen, Sidse, Terp, Mikkel G., Portman, Neil, Tuttolomondo, Martina, Gammelgaard, Odd L., Hundebøl, Monique F., Kaminska, Kamila, Johansen, Lene E., Bak, Martin, Honeth, Gabriella, Bosch, Ana, Lim, Elgene, Ditzel, Henrik J.
Publicado 2021